Cargando…
Pilot Outreach Program in Remedis—The Promising Step toward HCV Elimination among People Who Inject Drugs
The global effort to eliminate HCV infection requires new approaches to accessing and testing the affected population in a setting with as low of a threshold as possible. The focus should be on socially marginalized people who inject drugs (PWIDs) and who are not willing or able to visit standard me...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9819867/ https://www.ncbi.nlm.nih.gov/pubmed/36612821 http://dx.doi.org/10.3390/ijerph20010501 |
_version_ | 1784865333234892800 |
---|---|
author | Krekulová, Laura Damajka, Tomáš Krumphanslová, Zuzana Řehák, Vratislav |
author_facet | Krekulová, Laura Damajka, Tomáš Krumphanslová, Zuzana Řehák, Vratislav |
author_sort | Krekulová, Laura |
collection | PubMed |
description | The global effort to eliminate HCV infection requires new approaches to accessing and testing the affected population in a setting with as low of a threshold as possible. The focus should be on socially marginalized people who inject drugs (PWIDs) and who are not willing or able to visit standard medical services. With this vision, we established an outreach service—a testing point in an ambulance in the park in front of the Main Railway Station of the capital city of Prague—to provide bloodborne disease testing and treatment. The service was available every week on Wednesday afternoon. Over the initial two years of our experience, 168 unique people were tested. Of them, 82 (49%) were diagnosed with chronic HCV infection and were eligible for treatment with antivirals. Of these, 24 (29%) initiated antiviral treatment over the study period, and 17 (71%) of these individuals achieved a documented sustained virological response. Offering medical services in PWIDs’ neighborhoods helps overcome barriers and increase the chances that they will become patients and begin HCV treatment. The described outcomes appear promising for reaching the vision of linkage to the care of such a hard-to-reach population and can serve as a feasible model of care for further expansion. |
format | Online Article Text |
id | pubmed-9819867 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98198672023-01-07 Pilot Outreach Program in Remedis—The Promising Step toward HCV Elimination among People Who Inject Drugs Krekulová, Laura Damajka, Tomáš Krumphanslová, Zuzana Řehák, Vratislav Int J Environ Res Public Health Article The global effort to eliminate HCV infection requires new approaches to accessing and testing the affected population in a setting with as low of a threshold as possible. The focus should be on socially marginalized people who inject drugs (PWIDs) and who are not willing or able to visit standard medical services. With this vision, we established an outreach service—a testing point in an ambulance in the park in front of the Main Railway Station of the capital city of Prague—to provide bloodborne disease testing and treatment. The service was available every week on Wednesday afternoon. Over the initial two years of our experience, 168 unique people were tested. Of them, 82 (49%) were diagnosed with chronic HCV infection and were eligible for treatment with antivirals. Of these, 24 (29%) initiated antiviral treatment over the study period, and 17 (71%) of these individuals achieved a documented sustained virological response. Offering medical services in PWIDs’ neighborhoods helps overcome barriers and increase the chances that they will become patients and begin HCV treatment. The described outcomes appear promising for reaching the vision of linkage to the care of such a hard-to-reach population and can serve as a feasible model of care for further expansion. MDPI 2022-12-28 /pmc/articles/PMC9819867/ /pubmed/36612821 http://dx.doi.org/10.3390/ijerph20010501 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Krekulová, Laura Damajka, Tomáš Krumphanslová, Zuzana Řehák, Vratislav Pilot Outreach Program in Remedis—The Promising Step toward HCV Elimination among People Who Inject Drugs |
title | Pilot Outreach Program in Remedis—The Promising Step toward HCV Elimination among People Who Inject Drugs |
title_full | Pilot Outreach Program in Remedis—The Promising Step toward HCV Elimination among People Who Inject Drugs |
title_fullStr | Pilot Outreach Program in Remedis—The Promising Step toward HCV Elimination among People Who Inject Drugs |
title_full_unstemmed | Pilot Outreach Program in Remedis—The Promising Step toward HCV Elimination among People Who Inject Drugs |
title_short | Pilot Outreach Program in Remedis—The Promising Step toward HCV Elimination among People Who Inject Drugs |
title_sort | pilot outreach program in remedis—the promising step toward hcv elimination among people who inject drugs |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9819867/ https://www.ncbi.nlm.nih.gov/pubmed/36612821 http://dx.doi.org/10.3390/ijerph20010501 |
work_keys_str_mv | AT krekulovalaura pilotoutreachprograminremedisthepromisingsteptowardhcveliminationamongpeoplewhoinjectdrugs AT damajkatomas pilotoutreachprograminremedisthepromisingsteptowardhcveliminationamongpeoplewhoinjectdrugs AT krumphanslovazuzana pilotoutreachprograminremedisthepromisingsteptowardhcveliminationamongpeoplewhoinjectdrugs AT rehakvratislav pilotoutreachprograminremedisthepromisingsteptowardhcveliminationamongpeoplewhoinjectdrugs |